Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: Am J Med. 2019 May 29;132(11):1311–1319. doi: 10.1016/j.amjmed.2019.05.012

Table 2.

Outcomes by the receipt of digoxin before hospital discharge in 1531 pairs of propensity score-matched patients with heart failure with left ventricular ejection fraction ≤45% who were not receiving digoxin before hospital admission (CI= confidence interval)

Events (%) Hazard Ratio Associated with Digoxin Use (95% confidence interval)
No digoxin (n=1531) Digoxin (n=1531)
Heart failure readmission
 30 days 166 (11%) 125 (8%) 0.74 (0.59–0.93); p=0.010
 1 year 550 (36%) 471 (31%) 0.81 (0.72–0.92); p=0.001
 6 years 769 (50%) 737 (48%) 0.90 (0.81–0.99); p=0.037
All-cause readmission
 30 days 364 (24%) 332 (22%) 0.90 (0.78–1.04); p=0.163
 1 year 1007 (66%) 955 (62%) 0.91 (0.83–0.99); p=0.029
 6 years 1296 (85%) 1278 (84%) 0.92 (0.85–0.99); p=0.041
All-cause mortality
 30 days 106 (7%) 90 (6%) 0.84 (0.64–1.12); p=0.230
 1 year 495 (32%) 473 (31%) 0.94 (0.83–1.07); p=0.360
 6 years 1048 (69%) 1057 (69%) 1.00 (0.92–1.09); p=0.990
Heart failure readmission or all-cause mortality
 30 days 253 (17%) 207 (14%) 0.80 (0.67–0.96); p=0.019
 1 year 856 (56%) 788 (52%) 0.87 (0.79–0.96); p=0.006
 6 years 1284 (84%) 1268 (83%) 0.92 (0.86–0.99); p=0.045
All-cause readmission or all-cause mortality
 30 days 422 (28%) 388 (25%) 0.91 (0.79–1.04); p=0.165
 1 year 1142 (75%) 1098 (72%) 0.92 (0.85–0.99); p=0.046
 6 years 1464 (96%) 1454 (95%) 0.93 (0.87–1.00); p=0.050